AU6270794A - Treatment of allergic responses using mhc-peptide complexes - Google Patents
Treatment of allergic responses using mhc-peptide complexesInfo
- Publication number
- AU6270794A AU6270794A AU62707/94A AU6270794A AU6270794A AU 6270794 A AU6270794 A AU 6270794A AU 62707/94 A AU62707/94 A AU 62707/94A AU 6270794 A AU6270794 A AU 6270794A AU 6270794 A AU6270794 A AU 6270794A
- Authority
- AU
- Australia
- Prior art keywords
- mhc
- treatment
- peptide complexes
- allergic responses
- allergic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 208000026935 allergic disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
- A61K39/36—Allergens from pollen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70539—MHC-molecules, e.g. HLA-molecules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/605—MHC molecules or ligands thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
- A61K2039/622—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier non-covalent binding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Botany (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2381593A | 1993-02-25 | 1993-02-25 | |
| US023815 | 1993-02-25 | ||
| PCT/US1994/001919 WO1994018998A1 (fr) | 1993-02-25 | 1994-02-24 | Traitements de reactions allergiques au moyen de complexes peptidiques de mhc |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU6270794A true AU6270794A (en) | 1994-09-14 |
Family
ID=21817341
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU62707/94A Abandoned AU6270794A (en) | 1993-02-25 | 1994-02-24 | Treatment of allergic responses using mhc-peptide complexes |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU6270794A (fr) |
| WO (1) | WO1994018998A1 (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7074904B2 (en) | 1994-07-29 | 2006-07-11 | Altor Bioscience Corporation | MHC complexes and uses thereof |
| US5869270A (en) * | 1996-01-31 | 1999-02-09 | Sunol Molecular Corporation | Single chain MHC complexes and uses thereof |
| US6232445B1 (en) | 1997-10-29 | 2001-05-15 | Sunol Molecular Corporation | Soluble MHC complexes and methods of use thereof |
| US20240382606A1 (en) * | 2021-04-20 | 2024-11-21 | Georgia Tech Research Corporation | Nanoparticles for antigen-specific cell programming and uses thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5194425A (en) * | 1988-06-23 | 1993-03-16 | Anergen, Inc. | Mhc-mediated toxic conjugates useful in ameliorating autoimmunity |
| US5130297A (en) * | 1988-06-23 | 1992-07-14 | Anergen, Inc. | Conjugates useful in ameliorating autoimmunity MHC-II-peptide |
-
1994
- 1994-02-24 AU AU62707/94A patent/AU6270794A/en not_active Abandoned
- 1994-02-24 WO PCT/US1994/001919 patent/WO1994018998A1/fr active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO1994018998A1 (fr) | 1994-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU3738293A (en) | Compounds useful for treating allergic and inflammatory diseases | |
| AU6916694A (en) | Novel treatments for allergic diseases | |
| AU6797094A (en) | Cosmetic treatment of substrates | |
| AU4670293A (en) | Non-invasive testing | |
| AU7419096A (en) | Treatment of vegetables | |
| AU6808194A (en) | Reconstructed human antibody against human interleukin-6 | |
| AU6801694A (en) | The treatment of small animals | |
| AU618231B3 (en) | Treatment of emulsions | |
| AU1115095A (en) | Treatment of cellulose | |
| AU3538695A (en) | Iodine-based germicide and method | |
| AU1438295A (en) | Method for treatment of papulo-pustules and comedones of the skin | |
| AU6388494A (en) | Skin care composition | |
| AU6176094A (en) | Eye examination apparatus and accessory therefor | |
| AU6723294A (en) | Use of simmondsine | |
| AU6270794A (en) | Treatment of allergic responses using mhc-peptide complexes | |
| AU5340594A (en) | Skin treatment | |
| AU5737494A (en) | Human thrombospondin-4 | |
| GB9211736D0 (en) | Allergic treatment | |
| AU6651794A (en) | Automatisation of electro-oculographic examination | |
| AU7565894A (en) | Acupuncture treatment of common baldness | |
| AU673961B2 (en) | Methods of inhibiting the effects of amyloidogenic proteins | |
| AU5293293A (en) | Methods and compositions for treatment of allergic disease | |
| AU8879691A (en) | Treatment of dispersions | |
| AU3053295A (en) | Use of acetal-containing mixtures | |
| AU6366994A (en) | Methods for diagnosis and treatment of xscid |